ArticleWorld journal of gastrointestinal pharmacology and therapeutics2026

Risankizumab redefines Crohn's treatment after ustekinumab failure.

Felix Pius OmulloPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.